E. Mallon

Correlation between immunohistochemistry (HercepTest) and fluorescence <i>in situ</i> hybridization (FISH) for HER‐2 in 426 breast carcinomas from 37 centres

Mitch Dowsett, J. M. S. Bartlett, Janine Salter et al. · The Journal of Pathology · 2003 · 235 citations

Medicine, Oncology, Pathology +17

Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial

R.W. Blamey, T Bates, U Chetty et al. · European Journal of Cancer · 2013 · 221 citations

Medicine, Oncology, Surgery +16

Recommendations for HER2 testing in the UK

Ian O. Ellis, Mitch Dowsett, John M.S. Bartlett et al. · Journal of Clinical Pathology · 2000 · 142 citations · Full text

Medicine, Oncology, Pathology +17

NEOCENT: a randomised feasibility and translational study comparing neoadjuvant endocrine therapy with chemotherapy in ER-rich postmenopausal primary breast cancer

Carlo Palmieri, Susan Cleator, Lucy Kilburn et al. · Breast Cancer Research and Treatment · 2014 · 102 citations · Full text

Medicine, Endocrinology, Oncology +14

Poor survival outcomes in HER2-positive breast cancer patients with low-grade, node-negative tumours

Sian Tovey, S. Brown, J. Doughty et al. · British Journal of Cancer · 2009 · 101 citations · Full text

Medicine, Oncology, Pharmacotherapy +17